Polish Bioinformatics company backs US movement into Microbiome Research

18/05/2016 - 2 minutes

In Kraków, the Bioinformatics company Ardigen has now partnered up with a US based Microbiome startup, EpiBiome, which is looking for the answer to antibiotic resistance.

ardigen_microbiome_epibiome_obama_microbiome_bioinformatics_biotech This is another example of cross-Atlantic collaboration in the Microbiome world, just as President Obama pledges €105M ($121M) to the up and coming field of therapeutics.

It’s a growing area of research, and as we spoke to Isabelle de Cremoux (founder of the biggest Microbiome fund in the World) last week, the past 12 months have seen a crazy surge in investment, research focus and new initiatives being founded on the Human Microbiome.

Ardigen is one such bioinformatics company to join this movement, based on combination of bio-data science and complementary advanced software support. Their services also include Laboratory information management systems (LIMS) and analytical tools for research.

On the other hand, EpiBiome, is a precision microbiome engineering company based in California.

epibiome_biotech_ardigen_microbiome_fund_bacteriophages_infectious_disease

EpiBiome’s mission is to develop effective and sustainable FDA-approved therapies to combat infectious disease in humans and in agriculture without the use of antibiotics.

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!

Support Us

Become a Member